Congratulations Dr Ulf Schmitz who has been awarded a 2019 Australia-India Strategic Research Fund (AISRF) Early-and-Mid-Career Researcher (EMCR) Fellowship.
Dr Schmitz is Head of the Computational BioMedicine Laboratory within Centenary’s Gene and Stem Cell Program.
The AISRF EMCR Fellowship scheme offers successful applicants financial support worth up to $16,500 to travel to India and work with leading researchers at major Indian science and technology organisations for 1-3 months.
Dr Schmitz plans to visit two independent research centres in India, including the Centre of Computations Biology at IIIT Delhi and the Christian Medical College (CMC) in Vellore.
“India is arguably the biggest exporter of highly trained scholarly talents. This Fellowship will be a great opportunity for me to visit the source of these great Indian minds, and to establish productive collaborations,” says Dr Schmitz.
I’m glad and honored to be among the recipients of this fantastic Fellowship. https://t.co/V7X9LPIJGE
— Ulf Schmitz (@ulfschmitz) December 20, 2018
Professor John Rasko AO has led a world-first clinical trial into engineered stem cell treatment use, treating 15 patients with steroid resistant acute graft-versus-host disease.
Centenary Institute research has discovered that the lack of an enzyme in the liver called sphingosine kinase 2 results in pronounced insulin resistance and glucose intolerance, both symptoms of early stage type 2 diabetes.
Research led by the Centenary Institute has shown that a healthy weight and coffee consumption may help lower the risk of high-risk drinkers developing alcohol-induced cirrhosis.